Thomas Schweins
Corporate Officer/Principal bei QIAGEN N.V.
Profil
Thomas Schweins is currently the Director at QIAGEN Manchester Ltd.
since 2009 and the Senior Vice President-Life Science Business Area at QIAGEN NV since 2004.
Previously, he worked as a Director at Protagen AG, a Technology Manager at Hoechst AG, and a Principal at The Boston Consulting Group, Inc. Dr. Schweins has an undergraduate and graduate degree from the University of California, Los Angeles, a graduate degree from the University of Hannover, and a doctorate degree from the Max Planck Institute of Biochemistry.
Aktive Positionen von Thomas Schweins
| Unternehmen | Position | Beginn |
|---|---|---|
| QIAGEN N.V. | Corporate Officer/Principal | 01.01.2017 |
QIAGEN Manchester Ltd.
 QIAGEN Manchester Ltd. Pharmaceuticals: MajorHealth Technology Part of QIAGEN NV, QIAGEN Manchester Ltd. is a pharmaceutical manufacturing company. The company is based in Manchester, UK. QIAGEN Manchester was founded in 2001. | Direktor/Vorstandsmitglied | 25.11.2009 |
Ehemalige bekannte Positionen von Thomas Schweins
| Unternehmen | Position | Ende |
|---|---|---|
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Hoechst AG
 Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | Technik-/Wissenschafts-/F&E-Leiter | - |
Protagen AG
 Protagen AG BiotechnologyHealth Technology Protagen AG specializes in the development of novel diagnostic and companion diagnostic tests. Its products and services include GMP analyses, protein identification and analyses, proteome studies, UNIchip, clone and array, Bio-IT, Modiro as well as ProteinScape and Solver. The company was founded by Stefan Müllner, Helmut E. Meyer, Petra Weingarten and Martin Blüggel in 1997 and is headquartered in Dortmund, Germany. | Direktor/Vorstandsmitglied | - |
Ausbildung von Thomas Schweins
| University of Hannover | Graduate Degree |
| Max Planck Institute of Biochemistry | Doctorate Degree |
| University of California, Los Angeles | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| QIAGEN N.V. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Protagen AG
Protagen AG BiotechnologyHealth Technology Protagen AG specializes in the development of novel diagnostic and companion diagnostic tests. Its products and services include GMP analyses, protein identification and analyses, proteome studies, UNIchip, clone and array, Bio-IT, Modiro as well as ProteinScape and Solver. The company was founded by Stefan Müllner, Helmut E. Meyer, Petra Weingarten and Martin Blüggel in 1997 and is headquartered in Dortmund, Germany. | Health Technology |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Commercial Services |
Hoechst AG
Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | Process Industries |
QIAGEN Manchester Ltd.
QIAGEN Manchester Ltd. Pharmaceuticals: MajorHealth Technology Part of QIAGEN NV, QIAGEN Manchester Ltd. is a pharmaceutical manufacturing company. The company is based in Manchester, UK. QIAGEN Manchester was founded in 2001. | Health Technology |
